MindWalk Holdings HYFT
NASDAQ HYFT
$1.29 -0.06 (-4.44%)
At close: Sep 9, 2026 · 4:00 PM EDT

MindWalk Holdings (HYFT) Income from Continuing Operations (2020 - 2026)

MindWalk Holdings' (HYFT) quarterly Income from Continuing Operations came in at -$3.4 million in Q2 2026, up 75.78% year-over-year from -$1.9 million in Q2 2025, and down 28.77% quarter-over-quarter from -$2.7 million in Q1 2026.

Analysis

MindWalk Holdings (HYFT) Income from Continuing Operations (2020 - 2026) Analysis & Trends

MindWalk Holdings (HYFT) has reported Income from Continuing Operations for 7 consecutive years, with -$3.4 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Income from Continuing Operations rose 75.78% year-over-year to -$3.4 million in Q2 2026; TTM through Apr 2026 was -$3.1 billion, a 24.05% increase from a year earlier, with the FY2026 full-year figure at -$11.2 million, up 62.47% from the prior year.
  • Income from Continuing Operations was -$3.4 million for Q2 2026 at MindWalk Holdings, down from -$2.7 million in the prior quarter.
  • Over five years, Income from Continuing Operations peaked at -$2.0 million in Q4 2025 and troughed at -$4.0 billion in Q3 2024.
  • A 5-year average of -$693.5 million and a median of -$5.7 million in 2022 frame the typical range for Income from Continuing Operations.
  • Across the five-year window, Income from Continuing Operations plunged 40254.8% in 2023 and soared 99.84% in 2024, its largest moves.
  • Over 5 years, Income from Continuing Operations stood at -$5.5 million in 2022, then tumbled by 39915.91% to -$2.2 billion in 2023, then soared by 99.84% to -$3.5 million in 2024, then jumped by 43.42% to -$2.0 million in 2025, then tumbled by 72.81% to -$3.4 million in 2026.
  • The last three Income from Continuing Operations figures came in at -$3.4 million (Q2 2026), -$2.7 million (Q1 2026), and -$2.0 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Iqvia Holdings 44.06 Bn 42.11 Bn 1.44 Bn 241.00 Mn
2 Medpace Holdings 16.50 Bn 16.00 Bn 201.64 Mn 121.36 Mn
3 Charles River Laboratories International 13.77 Bn 13.62 Bn 452.07 Mn -760,000.00
4 Icon 12.62 Bn 11.69 Bn 479.29 Mn 111.81 Mn
5 Fortrea Holdings 1.68 Bn 1.51 Bn 139.20 Mn -13.20 Mn
6 Evotec SE 661.34 Mn 235.46 Mn - -
7 Ginkgo Bioworks Holdings 442.79 Mn 358.26 Mn 18.44 Mn -57.32 Mn
8 Champions Oncology 72.49 Mn 72.62 Mn 7.03 Mn -667,000.00
9 MindWalk Holdings 61.66 Mn 53.38 Mn 1.82 Mn -3.43 Mn
10 VivoSim Labs 1.47 Mn 1.47 Mn - -2.74 Mn
Historic Data

Historic Data

Download Data
DateValue
Apr 30, 2026 -3.43 Mn
Jan 31, 2026 -2.66 Mn
Oct 31, 2025 -1.98 Mn
Jul 31, 2025 -3.09 Bn
Apr 30, 2025 -14.14 Mn
Jan 31, 2025 -19.63 Mn
Oct 31, 2024 -3.50 Mn
Jul 31, 2024 -4.05 Bn
Apr 30, 2024 -17.56 Mn
Jan 31, 2024 -3.05 Mn
Oct 31, 2023 -2.21 Bn
Jul 31, 2023 -3.03 Bn
Apr 30, 2023 -5.82 Mn
Jan 31, 2023 -3.32 Mn
Oct 31, 2022 -5.53 Mn
Jul 31, 2022 -7.52 Mn
Apr 30, 2022 -4.19 Mn
Jan 31, 2022 -3.57 Mn
Oct 31, 2021 -3.88 Mn
Jul 31, 2021 -2.97 Mn